SciClone Pharmaceuticals Inc (SCLN)

11.15
Prev Close 11.15
Day Low/High 11.15 / 11.20
52 Wk Low/High 8.55 / 11.43
Avg Volume 462.50K
Exchange
Shares Outstanding 52.19M
Market Cap 581.94M
EPS 0.60
Div & Yield N.A. (N.A)
4 Stocks Under $10 Moving Higher

4 Stocks Under $10 Moving Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

A Different Route to China

Wary investors should buy shares in US companies with strong commercial ties to the Asian nation.

Stocks Under $5: Discount Drug Name

Stocks Under $5: Discount Drug Name

Portfolio manager David Peltier analyzes a volatile, low-dollar drug stock.

9 Stocks On Winning Streaks With Significant Hedge Fund Buying

9 Stocks On Winning Streaks With Significant Hedge Fund Buying

Every now and then it⿿s nice to have assurance that hedge fund managers and professional stock pickers know what they⿿re doing, [...]

3 Stocks Under $10 Making Big Moves

3 Stocks Under $10 Making Big Moves

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

3 Biotech Stocks Under $10 Surging Higher

3 Biotech Stocks Under $10 Surging Higher

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits.

Tuesday Looks Like Sink or Swim

Tomorrow has the best opportunity this week for stocks to bounce strongly.

SciClone Rises On Unusually High Volume (SCLN)

SciClone Rises On Unusually High Volume (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) is trading at unusually high volume Friday with 2.2 million shares changing hands. It is currently at 4.4 times its average daily volume and trading up 28 cents (+4.2%).

SciClone Stock Hits New 52-Week High (SCLN)

SciClone Stock Hits New 52-Week High (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) hit a new 52-week high Monday as it is currently trading at $7, above its previous 52-week high of $6.97 with 296,592 shares traded as of 12:05 p.m. ET. Average volume has been 492,500 shares over the past 30 days.

The Bulls Hang On

Meanwhile, the trend followers are sitting on plenty of cash and feeling frustrated.

Skimming for Outperformers

Even as the broad market slid Wednesday, these names managed to do quite well.

SciClone Stock Gaps Up On Today's Open (SCLN)

SciClone Stock Gaps Up On Today's Open (SCLN)

Shares of SciClone Pharmaceuticals (Nasdaq:SCLN) were gapping up Wednesday morning with an open price 18.3% higher than Tuesday's closing price. The stock closed at $5.24 yesterday and opened today's trading at $6.20.

SciClone Reaches New 52-Week High (SCLN)

SciClone Reaches New 52-Week High (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) hit a new 52-week high Thursday as it is currently trading at $6.45, above its previous 52-week high of $6.40 with 66,025 shares traded as of 10:02 a.m. ET. Average volume has been 497,900 shares over the past 30 days.

SciClone Stock Hits New 52-Week High (SCLN)

SciClone Stock Hits New 52-Week High (SCLN)

SciClone Pharmaceuticals (Nasdaq:SCLN) hit a new 52-week high Monday as it is currently trading at $6.13, above its previous 52-week high of $6 with 379,901 shares traded as of 12:02 p.m. ET. Average volume has been 443,500 shares over the past 30 days.

10 Pharma Stocks With 100% Buy Ratings

10 Pharma Stocks With 100% Buy Ratings

Analysts have 100% buy recommendations and upside up to 147% on these stocks.

FedEx: Premarket Trading

FedEx: Premarket Trading

Shares of FedEx fell after the company reported that second-quarter earnings fell below expectations.

Bank of America: After-Hours Trading

Bank of America: After-Hours Trading

Bank of America, SciClone Pharmaceuticals, and AutoZone were among the stocks moving after Wednesday's closing bell.

Kahn Swick & Foti, LLC Announce Continuing Investigation Into SciClone Pharmaceuticals, Inc. – Firm Appointed Co-lead Counsel In Securities Class Action – SCLN

Kahn Swick & Foti, LLC ("KSF") and KSF partner Former Attorney General of Louisiana, Charles C.

Lieff Cabraser Heimann & Bernstein, LLP Announces Class Action Lawsuits Against SciClone Pharmaceuticals, Inc.

The law firm of Lieff Cabraser Heimann & Bernstein, LLP announces that class action lawsuits have been brought on behalf of purchasers of the common stock of SciClone Pharmaceuticals, Inc.

Ryan & Maniskas, LLP Announces Class Action Lawsuit Against SciClone Pharmaceuticals, Inc.

Ryan & Maniskas, LLP ( www.rmclasslaw.

Kendall Law Group Investigates SciClone Pharmaceuticals, Inc. For Shareholders

Kendall Law Group, a national securities firm led by a former federal judge Joe Kendall with attorneys that include a former U.

Robbins Umeda LLP Announces Investigation Of SciClone Pharmaceuticals, Inc.

Robbins Umeda LLP has commenced an investigation into possible breaches of fiduciary duty and other violations of the law by certain officers and directors at SciClone Pharmaceuticals, Inc.

Finkelstein Thompson LLP Announces Investigation Of SciClone Pharmaceuticals, Inc.

Finkelstein Thompson LLP announces that it is investigating potential shareholder claims concerning SciClone Pharmaceuticals, Inc.

Goldfarb Branham LLP Investigating SciClone Pharmaceuticals For Investors

Goldfarb Branham, LLP is investigating SciClone (NASDAQ: SCLN) for shareholders who purchased stock of the company.

Law Offices Of Howard G. Smith Announces Investigation On Behalf Of Shareholders Of SciClone Pharmaceuticals, Inc.

Law Offices of Howard G. Smith announces that it is investigating potential claims on behalf of the shareholders of SciClone Pharmaceuticals, Inc.

Levi & Korsinsky, LLP Investigates SciClone Pharmaceuticals, Inc.

Levi & Korsinsky is investigating SciClone Pharmaceuticals, Inc.

Tavakoli's Take, Collectables, Schwab Bond ETFs

Gregg Greenberg breaks down today's market action with guests Peter Crawford, senior VP at Charles Schwab, Janet Tavakoli, president of Tavakoli Structured Finance and Bobby Livingston, VP of sales and marketing at RR Auction.

Roy Jacobs & Associates Investigating SciClone Pharmaceuticals, Inc. For Possible Securities Law Violations ("SCLN")

Roy Jacobs & Associates announces that it is investigating SciClone Pharmaceuticals, Inc.

Kahn Swick & Foti, LLC And Former Attorney General Of Louisiana Announce Investigation Into SciClone Pharmaceuticals, Inc. - SCLN

The law firm of Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C.

Ambac, SciClone: Volume Movers

Several stocks trading below $5, including Ambac Financial, were moving on above-average volume Tuesday.